SCWorx Corp: Nasdaq panel grants continued listing

What happened

• On Oct 2, 2026 the Nasdaq Hearings Panel granted SCWorx Corp's request for reconsideration, determined the company demonstrates compliance with Nasdaq continued listing requirements, and approved continued listing on The Nasdaq Capital Market, subject to conditions including a one-year Panel Monitor.
• The filing reports that the company completed a 1-for-12 reverse stock split on Aug 3, 2026, completed a private placement on Sep 16, 2026 of 350,000 shares and warrants to purchase 350,000 shares, and that publicly held shares increased to 549,092 as of Sep 17, 2026.
• The filing states that the Panel issued a Sep 17, 2026 decision to delist without knowledge that the private placement had closed; the Panel's Oct 2, 2026 reconsideration decision notes Staff confirmation on Sep 30, 2026 that the company had regained compliance with the publicly held shares rule as of Sep 17, 2026 and that the closing bid price has been at or above $1.00 per share on every trading day since Aug 4, 2026.

Key details

• Sep 16, 2026: executed Securities Purchase Agreement for private placement of 350,000 shares and warrants to purchase 350,000 shares.
• Aug 3, 2026: completed 1-for-12 reverse stock split; closing bid price at or above $1.00 for 20 consecutive trading days ended Aug 31, 2026.
• As of Sep 17, 2026: publicly held shares reported at 549,092; Nasdaq trading had been suspended since Apr 14, 2026 and will be reinstated on a date to be scheduled by Nasdaq after the company satisfies the Panel's first condition and submits Nasdaq's reinstatement form (company submitted the form on Oct 5, 2026).
• Purchasers in the Sep 2026 private placement agreed not to exercise their termination right under the Purchase Agreement based on the Sep 17, 2026 decision; the company disclosed this agreement on Oct 5, 2026 to satisfy a Panel condition.

Why it may matter

• The filing reports Item 1.01 (entry into a material definitive agreement concerning the private placement and Purchasers' agreement not to terminate), Item 3.01 (notice and the Panel's reconsideration decision to grant continued listing), and Item 7.01 (Regulation FD disclosure via press release dated Oct 5, 2026).
• The filing says trading on Nasdaq will be reinstated after Nasdaq schedules a date following satisfaction of the Panel's condition and the company's submission of the reinstatement form.
• The filing does not show why the company acted.